Results 151 to 160 of about 5,061 (184)
Calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease
Ana Teresa Simões
openalex +1 more source
Development and characterization of transgenic mouse models for Machado-Joseph disease
Anabela Silva‐Fernandes
openalex +1 more source
Correlation between CAG repeat length and clinical features in Machado-Joseph disease.
Patrı́cia Maciel +9 more
openalex +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Machado-Joseph-Azorean Disease in India
Archives of Neurology, 1986Machado-Joseph-Azorean (MJA) disease is an autosomal-dominant multisystem motor degeneration (with cerebellar ataxia as an important manifestation) that is seen mainly in people of Portuguese descent. Recently, a family in Japan with probable MJA disease has been described.
N E, Bharucha +2 more
openaire +2 more sources
Clinical neuroscience (New York, N.Y.), 1995
Machado-Joseph disease (MJD) is a form of dominantly-inherited ataxia originally described in people of Azorean and Portuguese descent. The disorder has subsequently been identified in Japan, Brazil, Australia, and China. Average age of onset is 35 to 40.
L, Sudarsky, P, Coutinho
openaire +3 more sources
Machado-Joseph disease (MJD) is a form of dominantly-inherited ataxia originally described in people of Azorean and Portuguese descent. The disorder has subsequently been identified in Japan, Brazil, Australia, and China. Average age of onset is 35 to 40.
L, Sudarsky, P, Coutinho
openaire +3 more sources
Cognitive deficits in Machado‐Josephs disease
Annals of Neurology, 1996AbstractCognitive function was examined in 6 patients with genetically confirmed Machado‐Joseph disease (MJD) and 15 age‐and ethnically matched controls using a series of subtests from the Cambridge Neuropsychological Test Automated Battery (CANTAB), a touch screen‐based testing system previously validated in a number of movement and neurodegenerative ...
P, Maruff +5 more
openaire +2 more sources
Intrafamilial variability in Machado‐Joseph disease
Movement Disorders, 1996AbstractDominantly inherited ataxias resulting from different gene mutations are difficult to distinguish based on clinical phenotypes. We believe the phenotypic variability within families can be a clue to clinical diagnosis. We illustrate the range of phenotypes extending from levodopa‐responsive extrapyramidal disease to more purely ataxic syndromes
S H, Subramony, R D, Currier
openaire +2 more sources
Machado-Joseph Disease or Not?
Archives of Neurology, 1991To the Editor. —Eto and coworkers 1 describe 12 patients with a hereditary ataxia they believe most closely resembles spinopontine atrophy as described by Boiler and Segarra 2 in a large Rhode Island kindred, the family W, of English extraction. I have had contact with this family.
openaire +2 more sources
Clinical Features of Machado-Joseph Disease
2018Machado-Joseph disease (MJD) also known as Spinocerebellar ataxia type 3, is a hereditary neurodegenerative disease associated with severe clinical manifestations and premature death. Although rare, it is the most common autosomal dominant spinocerebellar ataxia worldwide and has a distinct geographic distribution, reaching peak prevalence in certain ...
Nuno, Mendonça +3 more
openaire +2 more sources
Sleep disorders in Machado–Joseph disease
Current Opinion in Psychiatry, 2016This article provides a description on clinical features and pathophysiology of the main sleep disorders observed in Machado-Joseph disease (MJD).Pathological studies have clearly demonstrated that degenerative process in MJD is widespread in the nervous system, and not restricted to the cerebellum.
José Luiz, Pedroso +9 more
openaire +2 more sources

